Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPS IIIA mice
- 31 March 2007
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 90 (3), 313-328
- https://doi.org/10.1016/j.ymgme.2006.10.005
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VIIProceedings of the National Academy of Sciences of the United States of America, 2005
- Direct Comparison of Measures of Endurance, Mobility, and Joint Function During Enzyme-Replacement Therapy of Mucopolysaccharidosis VI (Maroteaux-Lamy Syndrome): Results After 48 Weeks in a Phase 2 Open-Label Clinical Study of Recombinant Human N-Acetylgalactosamine 4-SulfatasePublished by American Academy of Pediatrics (AAP) ,2005
- Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrierProceedings of the National Academy of Sciences of the United States of America, 2004
- Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary reportActa Paediatrica, 2002
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseThe New England Journal of Medicine, 2001
- Enzyme Replacement Therapy in Fabry DiseaseJama-Journal Of The American Medical Association, 2001
- Enzyme-Replacement Therapy in Mucopolysaccharidosis IThe New England Journal of Medicine, 2001
- Structure and Sequence of the Human Sulphamidase GeneDNA Research, 1996
- Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndromeNature Genetics, 1995
- Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease.Proceedings of the National Academy of Sciences of the United States of America, 1990